Literature DB >> 15146442

Soluble CD154 plasma levels in patients with systemic lupus erythematosus: modulation by antiphospholipid antibodies.

Domenico Ferro1, Pasquale Pignatelli, Lorenzo Loffredo, Fabrizio Conti, Guido Valesini, Armando D'Angelo, Francesco Violi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15146442     DOI： 10.1002/art.20177

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  4 in total

1.  Aspirin in asymptomatic patients with a confirmed positivity of antiphospholipid antibodies.

Authors:  Stefania Basili; Francesco Violi
Journal:  Intern Emerg Med       Date:  2008-09-10       Impact factor: 3.397

Review 2.  CD154: an immunoinflammatory mediator in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  Nada Alaaeddine; Ghada S Hassan; Daniel Yacoub; Walid Mourad
Journal:  Clin Dev Immunol       Date:  2011-10-24

3.  The Inhibition of CD40/CD154 Costimulatory Signaling in the Prevention of Renal Transplant Rejection in Nonhuman Primates: A Systematic Review and Meta Analysis.

Authors:  Steven Perrin; Marianne Magill
Journal:  Front Immunol       Date:  2022-04-07       Impact factor: 8.786

4.  Therapeutic effects of anti-CD154 antibody in cynomolgus monkeys with advanced rheumatoid arthritis.

Authors:  Eun Wha Choi; Kyo Won Lee; Hyojun Park; Hwajung Kim; Jong Hyun Lee; Ji Woo Song; Jehoon Yang; Yeongbeen Kwon; Tae Min Kim; Jae Berm Park; Sungjoo Kim
Journal:  Sci Rep       Date:  2018-02-01       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.